Market Cap 2.30M
Revenue (ttm) 3.34M
Net Income (ttm) -10.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -316.47%
Debt to Equity Ratio -4.95
Volume 57,600
Avg Vol 68,002
Day's Range N/A - N/A
Shares Out 1.40M
Stochastic %K 76%
Beta -0.24
Analysts Strong Sell
Price Target $13.25

Company Profile

Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based cancer vaccine that has completed Phase 1/2a trial to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers, including non-small...

Industry: Biotechnology
Sector: Healthcare
Phone: 45 31 31 97 53
Website: evaxion.ai
Address:
Dr. Neergaards Vej, 5th Floor, Horsholm, Denmark
S2K_TradeZ
S2K_TradeZ Jul. 27 at 5:37 AM
🚨 Main watchlist - July 28th $NVNI 14.18% up Friday AH. Former 2000% runner. Hosted NuviniAI Day at Oracle Sao Paulo. Getting support from all time frame moving averages (DMA5, 10, 20, and 60). If it gaps up at the open, it could still run and give that push into 0.56-0.65. $HBIO Incoming CEO John Duke demonstrated strong performance at PMT with 20% annual revenue growth. Q2 2025 revenue guidance of $20.4M. Pt: 1+ $SOAR recent sale of GC aviation for 2M in cash. Their subscription sales continuing a rapid growth. FF is only 1.58. They reported 25.48M revenue last quarter. Next earning PR drop can push this over 2 fast. $EVAX debt conversion at $4.87. That's nearly 90% above the current price. 5.93M FF. No ATM. Secured Gates Foundation grant for polio vaccine using its AI-Immunology platform. All DMAs are aligned upward. 2.8 break on watch. Pt: 5+ Every setup here is solid. Catalysts, supports, floats, and chart structures are all emerged beautifully. Let's stay sharp and keep it going!
0 · Reply
ChartChartist
ChartChartist Jul. 27 at 1:40 AM
$EVAX slow upchannel since june bout 3.10 break to fly $PHH never invest in small caps trades only $IVF keep poppin gimme wicks 🥁 $OLB All the eyes getting on it, 4am trade too contender. Crypto tix still to run
0 · Reply
Pitts123
Pitts123 Jul. 26 at 5:47 PM
$EVAX I got a feeling $MRK is about to come steal this for the low of about 100+m while everyone is sleeping on it.
0 · Reply
Manwiththeplan
Manwiththeplan Jul. 26 at 9:03 AM
$EVAX Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine | Cancer Immunology, Immunotherapy https://share.google/0K7lk8fER0u0egCya
0 · Reply
Manwiththeplan
Manwiththeplan Jul. 26 at 9:02 AM
$EVAX low marcet cap. Data in october. Data is expected to be good. Possible payment bij Merck coming months.
0 · Reply
Manwiththeplan
Manwiththeplan Jul. 25 at 4:55 PM
$EVAX happy holding 24k shares
0 · Reply
Manwiththeplan
Manwiththeplan Jul. 25 at 4:49 PM
$EVAX i think buyout in next 2 months
0 · Reply
Manwiththeplan
Manwiththeplan Jul. 25 at 3:55 PM
$EVAX market cap is 16,7 million. Do not sell now
0 · Reply
Investor80
Investor80 Jul. 25 at 2:23 PM
$EVAX pumpers already selling the news?
0 · Reply
Investor80
Investor80 Jul. 25 at 2:22 PM
$EVAX who wants to ride this down?
0 · Reply
Latest News on EVAX
Evaxion receives grant funding to design new polio vaccine

Jun 3, 2025, 9:15 AM EDT - 7 weeks ago

Evaxion receives grant funding to design new polio vaccine


Evaxion to present at World Vaccine Congress

Apr 10, 2025, 8:00 AM EDT - 3 months ago

Evaxion to present at World Vaccine Congress


Evaxion Biotech A/S (EVAX) Q4 2024 Earnings Call Transcript

Apr 1, 2025, 11:21 AM EDT - 4 months ago

Evaxion Biotech A/S (EVAX) Q4 2024 Earnings Call Transcript


Evaxion announces closing of $10.8 million public offering

Jan 31, 2025, 4:05 PM EST - 6 months ago

Evaxion announces closing of $10.8 million public offering


Evaxion announces pricing of $10.8 million public offering

Jan 30, 2025, 8:00 AM EST - 6 months ago

Evaxion announces pricing of $10.8 million public offering


Evaxion announces completion of ADS ratio change

Jan 14, 2025, 4:05 PM EST - 6 months ago

Evaxion announces completion of ADS ratio change


Evaxion announces plan to implement ADS ratio change

Dec 30, 2024, 8:00 AM EST - 7 months ago

Evaxion announces plan to implement ADS ratio change


Evaxion Biotech Partners With Merck To Expand Vaccine Development

Sep 26, 2024, 10:53 AM EDT - 10 months ago

Evaxion Biotech Partners With Merck To Expand Vaccine Development

MRK


Evaxion Biotech A/S (EVAX) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 11:43 AM EDT - 1 year ago

Evaxion Biotech A/S (EVAX) Q2 2024 Earnings Call Transcript


Evaxion Receives Nasdaq Notification

May 10, 2024, 5:00 PM EDT - 1 year ago

Evaxion Receives Nasdaq Notification


Evaxion Biotech A/S (EVAX) Q4 2023 Earnings Call Transcript

Apr 2, 2024, 2:10 PM EDT - 1 year ago

Evaxion Biotech A/S (EVAX) Q4 2023 Earnings Call Transcript


S2K_TradeZ
S2K_TradeZ Jul. 27 at 5:37 AM
🚨 Main watchlist - July 28th $NVNI 14.18% up Friday AH. Former 2000% runner. Hosted NuviniAI Day at Oracle Sao Paulo. Getting support from all time frame moving averages (DMA5, 10, 20, and 60). If it gaps up at the open, it could still run and give that push into 0.56-0.65. $HBIO Incoming CEO John Duke demonstrated strong performance at PMT with 20% annual revenue growth. Q2 2025 revenue guidance of $20.4M. Pt: 1+ $SOAR recent sale of GC aviation for 2M in cash. Their subscription sales continuing a rapid growth. FF is only 1.58. They reported 25.48M revenue last quarter. Next earning PR drop can push this over 2 fast. $EVAX debt conversion at $4.87. That's nearly 90% above the current price. 5.93M FF. No ATM. Secured Gates Foundation grant for polio vaccine using its AI-Immunology platform. All DMAs are aligned upward. 2.8 break on watch. Pt: 5+ Every setup here is solid. Catalysts, supports, floats, and chart structures are all emerged beautifully. Let's stay sharp and keep it going!
0 · Reply
ChartChartist
ChartChartist Jul. 27 at 1:40 AM
$EVAX slow upchannel since june bout 3.10 break to fly $PHH never invest in small caps trades only $IVF keep poppin gimme wicks 🥁 $OLB All the eyes getting on it, 4am trade too contender. Crypto tix still to run
0 · Reply
Pitts123
Pitts123 Jul. 26 at 5:47 PM
$EVAX I got a feeling $MRK is about to come steal this for the low of about 100+m while everyone is sleeping on it.
0 · Reply
Manwiththeplan
Manwiththeplan Jul. 26 at 9:03 AM
$EVAX Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine | Cancer Immunology, Immunotherapy https://share.google/0K7lk8fER0u0egCya
0 · Reply
Manwiththeplan
Manwiththeplan Jul. 26 at 9:02 AM
$EVAX low marcet cap. Data in october. Data is expected to be good. Possible payment bij Merck coming months.
0 · Reply
Manwiththeplan
Manwiththeplan Jul. 25 at 4:55 PM
$EVAX happy holding 24k shares
0 · Reply
Manwiththeplan
Manwiththeplan Jul. 25 at 4:49 PM
$EVAX i think buyout in next 2 months
0 · Reply
Manwiththeplan
Manwiththeplan Jul. 25 at 3:55 PM
$EVAX market cap is 16,7 million. Do not sell now
0 · Reply
Investor80
Investor80 Jul. 25 at 2:23 PM
$EVAX pumpers already selling the news?
0 · Reply
Investor80
Investor80 Jul. 25 at 2:22 PM
$EVAX who wants to ride this down?
0 · Reply
Wvhillbilly304
Wvhillbilly304 Jul. 25 at 1:27 PM
$EVAX $HCTI check out the news … cancer vaccine
0 · Reply
OTCshithead
OTCshithead Jul. 25 at 1:27 PM
$ABP Looking good trimmed ✅️ $EVAX Finally moving up, news today ⏳️ $PHIO Quick flip pre ✅️ $LIDR paying again ✅️ 🥳🍻
0 · Reply
caprihunter
caprihunter Jul. 25 at 1:21 PM
$EVAX THE ONE AND ONLY CANCER VACCINE THAT IS GIVING THE RESULT ON THE MARKET Strong interim results with 69% Overall Response Rate Tumor reduction observed in 15 out of 16 patients (94%) Statistically significant correlation (p=0.00013) between AI platform predictions and immune responses Acceptance to present at prestigious ESMO Congress indicates data significance $UNH $CMC $OP $IXHL
1 · Reply
OTCshithead
OTCshithead Jul. 25 at 1:21 PM
$EVAX Low float ✅️ Positive News about debt conversion at $4.87 ✅️ Presentation in Berlin Phase 2 October ⏳️ Analyst PT $8 - 38 With volume this has room to go lets see. I'm in with a great avg will keep holding lets see. ⏰️ Today: Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025 July 11 : EIB will purchase the warrants at a price of $4.87 corresponding to a premium of 89% to the share price by market close yesterday
0 · Reply
caprihunter
caprihunter Jul. 25 at 1:19 PM
$EVAX Tumor reduction observed in 15 out of 16 patients (94%) Statistically significant correlation (p=0.00013) between AI platform predictions and immune responses Acceptance to present at prestigious ESMO Congress indicates data significance CANCER VACCINE IS THE FUTURE $OCTO $ATNF $GSIW $ABP
1 · Reply
caprihunter
caprihunter Jul. 25 at 1:19 PM
$EVAX Tumor reduction observed in 15 out of 16 patients (94%) what are you waiting FOR!? $LHAI $MCVT $HTOO $HCTI
0 · Reply
OTCshithead
OTCshithead Jul. 25 at 1:12 PM
$EVAX ⏳️ Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025
0 · Reply
Dingo2
Dingo2 Jul. 25 at 1:06 PM
$EVAX finviz has Shares Float at 1.13M?? Damnnn!!
1 · Reply
Meltingflame
Meltingflame Jul. 25 at 1:06 PM
$EVAX Looks interesting with the presentation news.. watching. Also a low float with high short rate, definitely can catapult on the news.
0 · Reply
JL_TradeZ
JL_TradeZ Jul. 25 at 1:05 PM
$EVAX Another special play for you all. Hit the like if you guys are banking. Paytience pays again 💪
1 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 25 at 1:05 PM
$EVAX Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025 By Evaxion | July 25, 2025, 9:00 AM
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 25 at 1:05 PM
$EVAX pt 3.5
0 · Reply